Onapristone companion diagnostic - Arno Therapeutics
Alternative Names: Activated progestrone receptors diagnostic - Arno Therapeutics; APR diagnostic - Arno TherapeuticsLatest Information Update: 27 Sep 2021
At a glance
- Originator Arno Therapeutics
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Breast cancer; Ovarian cancer; Prostate cancer; Uterine cancer
- No development reported Endometrial cancer
Most Recent Events
- 27 Sep 2021 No development reported - Phase-II for Endometrial cancer (Diagnosis, Metastatic disease, Recurrent, Treatment-experienced) in France (unspecified route) (Arno Therapeutics, September 2021)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Breast-cancer(Diagnosis) in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Endometrial-cancer(Diagnosis) in USA